Funder: Alzheimer's Drug Discovery Foundation
Due Dates: January 12, 2026 (Invited full proposal) | September 14, 2026 (Letter of Intent)
Funding Amounts: Up to $5,000,000 per award; multi-year projects supported; direct costs only.
Summary: Supports IND-enabling studies and early-phase clinical trials for novel pharmacological interventions and devices targeting Alzheimer’s disease and related dementias.
Key Information: Excludes anti-amyloid approaches and cholinesterase inhibitors; funding is via mission-related investments with ROI requirements.